The Conversation (0)
Life Science Big News Roundup: Cardiovascular Performance Improvements Discovered in Lexaria’s TurboCBD(TM) Capsules Clinical Trail; NanoSphere Signs Definitive Licensing Agreement in Oregon; Biocure Signs MOU with Government of Uzbekistan and Gold-Dream LLC to Build Biosimilars Manufacturing Plant;
Feb. 22, 2019 10:00AM PST
Life Science Investing News
In case you missed it, here is this week’s life science big news roundup.
In case you missed it, here is this week’s life science big news roundup:
Biotech:
- Cardiovascular Performance Improvements including Lower Blood Pressure Discovered from Human Clinical Trial using Lexaria’s DehydraTECH(TM) Powered TurboCBD(TM) Capsules
- MediPharm Labs Signs First International Private Label Sale Agreement With AusCann for Cannabis Oil Export to Australia
- NanoSphere Signs Definitive Licensing Agreement in Oregon
- Biocure Technology Corp Announces a MOU with the Government of Uzbekistan and Gold-Dream LLC to Build a Manufacturing Plant to Produce Biosimilars
To see our previous Life Science Investing Big News Roundups, please click here.